Dr. Plotkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Yaw 9
Brain Tumor Center Neuro-Oncology
Boston, MA 02114Phone+1 617-724-8770Fax+1 617-724-8769
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 2002 - 2003
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1999 - 2002
Tulane UniversityInternship, Internal Medicine, 1998 - 1999- Tulane University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2024 - 2026
MA State Medical License 2002 - 2025
NH State Medical License 2023 - 2025
LA State Medical License 2002 - 2002- American Board of Psychiatry and Neurology Neurology
- United council of neurological subspecialtiesNeuro-Oncology
Clinical Trials
- Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1 Start of enrollment: 2008 Mar 01
- Concentration and Activity of Lapatinib in Vestibular Schwannomas Start of enrollment: 2009 Jun 01
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rizzo 3rd
Acta Neuropathologica. 2024-08-16 - 1 citationsPlatform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.Britt A E Dhaenens, Günter Heimann, Annette Bakker, Marco Nievo, Rosalie E Ferner
Neuro-Oncology Practice. 2024-08-01 - Evolving concepts in meningioma management in the era of genomics.Annie L Hsieh, Wenya Linda Bi, Vijaya Ramesh, Priscilla K Brastianos, Scott R Plotkin
Cancer. 2024-08-01
Journal Articles
- Increasing Access to Specialty Care for Rare Diseases: A Case Study Using a Foundation Sponsored Clinic Network for Patients with Neurofibromatosis 1, Neurofibromatosi...Scott R Plotkin, Justin T Jordan, BioMed Central
Press Mentions
University of Miami Miller School of Medicine Selected for National NF2 Tumor Clinical TrialJune 1st, 2022
Wayne Biopharma Firm Targeting Rare Genetic Disorders Raises $6MMay 1st, 2020
Antiangiogenesis Treatment Improves Hearing in Some NF2 PatientsJuly 8th, 2009- Join now to see all
Grant Support
- Fetal Alcohol Effects On Blood Brain Barrier TransportNational Institute On Alcohol Abuse And Alcoholism1995–1997
- Fetal Alcohol Effects On Blood Brain Barrier TransportNational Institute On Alcohol Abuse And Alcoholism1994
Professional Memberships
- Member
Industry Relationships
- Co-Founder, NF2 Therapeutics
- Co-Founder, NFlection Therapeutics
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
